Standard risk assessment forms help reduce preventable harm in older adult inpatients: A retrospective chart review study

2021 ◽  
Author(s):  
Chin‐Yen Han ◽  
Bernice Redley ◽  
Chun‐Chih Lin ◽  
Li‐Chin Chen ◽  
Chip Jin Ng ◽  
...  
Keyword(s):  
Risk Assessment ◽  
Older Adult ◽  
Chart Review ◽  
Retrospective Chart Review ◽  
Review Study ◽  
Preventable Harm ◽  
Standard Risk

Improving patient safety in Palestinian hospitals: a cross-sectional and retrospective chart review study

The Lancet ◽  
2018 ◽  
Vol 391 ◽  
pp. S44
Author(s):  
Shahenaz Najjar ◽  
Nashat Nafouri ◽  
Kris Vanhaecht ◽  
Martin Euwema
Keyword(s):  
Patient Safety ◽  
Chart Review ◽  
Retrospective Chart Review ◽  
Cross Sectional ◽  
Review Study

scholarly journals Tuberous sclerosis complex: Clinical spectrum and epilepsy: A retrospective chart review study

2018 ◽  
Vol 9 (1) ◽  
pp. 154-160
Author(s):  
Sulaiman Almobarak ◽  
Mohammad Almuhaizea ◽  
Musaad Abukhaled ◽  
Suad Alyamani ◽  
Omar Dabbagh ◽  
...  
Keyword(s):  
Tuberous Sclerosis ◽  
Gene Mutation ◽  
Tuberous Sclerosis Complex ◽  
Chart Review ◽  
Clinical Presentation ◽  
Retrospective Chart Review ◽  
Neurocutaneous Disorder ◽  
Development Delay ◽  
Review Study ◽  
New Onset

Abstract Tuberous sclerosis complex (TSC) is an autosomal dominant genetic neurocutaneous disorder, with heterogeneous manifestations. We aimed to review the clinical presentation of TSC and its association with epilepsy among Saudi population. This was a retrospective chart review study of 88 patients diagnosed with TSC with or without epilepsy. In 38.6% of patients, symptoms began before 1 year of age. The most frequent initial manifestations of TSC were new onset of seizures (68.2%), skin manifestations (46.6%) and development delay (23.9%). During the evolution of the disease 65.9% had epilepsy, 17% facial angiofibromas, 13.6% Shagreen patch, 18.2% heart rhabdomyomas and 12.5% retinal hamartomas. The genetic study for TSC diagnosis was done for 44 patients, 42 (95,4%) of them were genetically confirmed, for whom 13 patients had TSC1 mutation (29.5%), 29 patients were carrying TSC2 gene mutation (65.9%), Genetic test for TSC 1 and TSC 2 were negative for 2 patients (4.5%) despite positive gene mutation in their relative with TSC. The most common manifestations were central nervous system (predominantly epilepsy) and dermatological manifestations. Most of the patients develop epilepsy with multiple seizure types. TSC 2 mutation is more common than TSC 1 mutation.

scholarly journals Mortality in the Gaza Strip during the period July to September, 2014: a retrospective chart review study

The Lancet ◽  
2017 ◽  
Vol 390 ◽  
pp. S12
Author(s):  
Mohammad Yaghi ◽  
Arild Vaktskjold ◽  
Osama A Balawi ◽  
Mahmoud Deeb Daher ◽  
Wendy Venter
Keyword(s):  
Chart Review ◽  
Gaza Strip ◽  
Retrospective Chart Review ◽  
Review Study ◽  
The Gaza Strip
Sign in / Sign up

Export Citation Format

Share Document